An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med. 1997;29:13 87. 86. Fesmire FM, Percy RF, Bardoner JB, et al. Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med. 1998;31:3 11. 87. Haaf P, Reichlin T, Corson N, et al. B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain. Am J Med. 2011;124:444 52. 88. Brown AM, Sease KL, Robey JL, et al. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Ann Emerg Med. 2007;49:153 63. 89. Heeschen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natri- uretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation. 2004;110:3206 12. 90. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natri- uretic peptide for risk assessment in unstable angina/non-ST-elevation myocardialinfarction:B-typenatriureticpeptideandprognosisinTACTICS- TIMI 18. J Am Coll Cardiol. 2003;41:1264 72. 91. James SK, Lindback J, Tilly J, et al. Troponin-T and N-terminal pro-B- type natriuretic peptide predict mortality benefit from coronary revascu- larization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol. 2006;48:1146 54. 92. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/ IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998;339:436 43. 93. Effects of tissue plasminogen activator and a comparison of early inva- sive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. 